Titel

Merkliste
1 Ergebnisse

Phase III, randomized trial of mirvetuximab soravtansine ve..:

Moore, KN ; Oza, AM ; Colombo, N...
Annals of oncology : official journal of the European Society for Medical Oncology, 2021, 32 (6), pp. 757 - 765. , 2021

Link: https://repository.icr.ac.uk/handle/internal/4748

RT Journal
T1 <Title>Phase III, randomized trial of mirvetuximab soravtansine versus chemotherapy in patients with platinum-resistant ovarian cancer: primary analysis of FORWARD I</Title>

UL https://suche.suub.uni-bremen.de/peid=base-ftinstcancerres:oai:repository.icr.ac.uk:internal_4748&Exemplar=1&LAN=DE
				
A1 Moore, KN
A1 Oza, AM
A1 Colombo, N
A1 Oaknin, A
A1 Scambia, G
A1 Lorusso, D
A1 Konecny, GE
A1 Banerjee, S
A1 Murphy, CG
A1 Tanyi, JL
A1 Hirte, H
A1 Konner, JA
A1 Lim, PC
A1 Prasad-Hayes, M
A1 Monk, BJ
A1 Pautier, P
A1 Wang, J
A1 Berkenblit, A
A1 Vergote, I
A1 Birrer, MJ
YR 2021
K1 Humans
K1 Ovarian Neoplasms
K1 Maytansine
K1 Antineoplastic Combined Chemotherapy Protocols
K1 Immunoconjugates
K1 Drug Resistance
K1 Neoplasm
K1 Female
K1 Antibodies
K1 Monoclonal
K1 Humanized
K1 Carcinoma
K1 Ovarian Epithelial
JF Annals of oncology : official journal of the European Society for Medical Oncology, 2021, 32 (6), pp. 757 - 765
LK http://dx.doi.org/https://repository.icr.ac.uk/handle/internal/4748
DO https://repository.icr.ac.uk/handle/internal/4748
SF ELIB - SuUB Bremen

Export

RefWorks (nur Desktop-Version!)
Flow (Zuerst in Flow einloggen, dann importieren)